The purpose of this study was to assess whether the volume transfer constant (Ktrans) from dynamic contrast‐enhanced (DCE) perfusion brain MR could assist in identifying the HER2 status of breast cancer brain metastases. The gene discussed is ERBB2; the disease is breast carcinoma.